Literature DB >> 18450828

Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure.

Katherine A Barraclough1, Lesley A Stevens, Lee Er, Debbie Rosenbaum, Jacqueline Brown, Pari Tiwari, Adeera Levin.   

Abstract

BACKGROUND: Coronary artery calcification (CAC) is prevalent in patients with chronic kidney disease (CKD). Data on the reliability and validity of high-resolution computerized tomography (HRCT) in patients with CKD is lacking. The purpose of this study was to evaluate the inter- and intra-reviewer agreement and inter-scan reproducibility of CACS measurement with HRCT in a cohort of patients with CKD prior to dialysis, and to compare the change in CACS at 30 minutes to the change in CACS over 1 year.
METHODS: Thirty-three patients with CKD not yet on dialysis underwent an HRCT scan at baseline and 1 year to assess for CAC and CAC progression. Two radiologists independently reviewed films and each radiologist re-reviewed a randomly selected subset of films they had previously viewed, to assess for inter-reviewer and intra-reviewer reliability, respectively. Patients underwent a repeat scan within 30 min of the first baseline scan to assess for inter-scan reproducibility.
RESULTS: At baseline, eight patients (24%) had no CAC. Of the 25 patients (76%) with CAC, 10 (40%) had severe calcification. Intra-reviewer agreement was 83%. Inter-reviewer agreement ranged between 77 and 94%. Six (27%) of the patients with >30 baseline CACS had >15% change in CACS following repositioning. Four of these patients had an increase in CACS with position change [18% (95% CI: 5-40%)]. Of the 21 patients who underwent a follow-up scan at 1 year, 7 (33%) demonstrated CACS progression.
CONCLUSIONS: There is significant imprecision in HRCT-derived CACS in CKD patients. This suggests a need for standardization of methods of CACS measurement with HRCT.

Entities:  

Mesh:

Year:  2008        PMID: 18450828      PMCID: PMC3108343          DOI: 10.1093/ndt/gfn234

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  22 in total

1.  Reproducibility of three different scoring systems for measurement of coronary calcium.

Authors:  Hideya Yamamoto; Matthew J Budoff; Bin Lu; Junichiro Takasu; Ronald J Oudiz; Songshou Mao
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

2.  Reproducibility and accuracy of coronary calcium measurements with multi-detector row versus electron-beam CT.

Authors:  Andreas F Kopp; Bernd Ohnesorge; Christoph Becker; Stephen Schröder; Martin Heuschmid; Axel Küttner; Ronald Kuzo; Claus D Claussen
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.

Authors:  A G Stack; W E Bloembergen
Journal:  Am J Kidney Dis       Date:  2001-11       Impact factor: 8.860

5.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

Authors:  Santhi K Ganesh; Austin G Stack; Nathan W Levin; Tempie Hulbert-Shearon; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

6.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

7.  Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study.

Authors:  Holly Kramer; Robert Toto; Ronald Peshock; Richard Cooper; Ronald Victor
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

8.  Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation.

Authors:  Michael Bursztyn; Michael Motro; Ehud Grossman; Joseph Shemesh
Journal:  J Hypertens       Date:  2003-10       Impact factor: 4.844

9.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.

Authors:  J Braun; M Oldendorf; W Moshage; R Heidler; E Zeitler; F C Luft
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

View more
  4 in total

1.  Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.

Authors:  Olga A Agapova; Yifu Fang; Toshifumi Sugatani; Michael E Seifert; Keith A Hruska
Journal:  Kidney Int       Date:  2016-03-11       Impact factor: 10.612

2.  The relationship between coronary artery calcium scores and left atrium size in hemodialysis patients.

Authors:  Ismail Baloglu; Kultigin Turkmen; H Zeki Tonbul; N Yılmaz Selcuk
Journal:  Int Urol Nephrol       Date:  2017-05-18       Impact factor: 2.370

Review 3.  Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.

Authors:  Varun Agrawal; Victor Marinescu; Mohit Agarwal; Peter A McCullough
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

4.  Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.

Authors:  Francesca Solagna; Caterina Tezze; Maja T Lindenmeyer; Shun Lu; Guochao Wu; Shuya Liu; Yu Zhao; Robert Mitchell; Charlotte Meyer; Saleh Omairi; Temel Kilic; Andrea Paolini; Olli Ritvos; Arja Pasternack; Antonios Matsakas; Dominik Kylies; Julian Schulze Zur Wiesch; Jan-Eric Turner; Nicola Wanner; Viji Nair; Felix Eichinger; Rajasree Menon; Ina V Martin; Barbara M Klinkhammer; Elion Hoxha; Clemens D Cohen; Pierre-Louis Tharaux; Peter Boor; Tammo Ostendorf; Matthias Kretzler; Marco Sandri; Oliver Kretz; Victor G Puelles; Ketan Patel; Tobias B Huber
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.